Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Clinical trial NCT00408590 · COMPLETED
Trial details
- NCT number
- NCT00408590
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-19
- Primary completion
- 2012-08-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.